Banco Bilbao Vizcaya Argentaria S.A. Lowers Position in Lam Research Corporation $LRCX

Banco Bilbao Vizcaya Argentaria S.A. lessened its stake in Lam Research Corporation (NASDAQ:LRCX) by 53.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 141,805 shares of the semiconductor company’s stock after selling 162,672 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Lam Research were worth $10,323,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Smallwood Wealth Investment Management LLC acquired a new position in shares of Lam Research during the 1st quarter worth approximately $26,000. West Paces Advisors Inc. acquired a new position in shares of Lam Research during the 4th quarter worth approximately $27,000. Mpwm Advisory Solutions LLC acquired a new position in shares of Lam Research during the 4th quarter worth approximately $27,000. Park Square Financial Group LLC acquired a new position in shares of Lam Research during the 4th quarter worth approximately $31,000. Finally, Putney Financial Group LLC acquired a new position in shares of Lam Research during the 4th quarter worth approximately $36,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Stock Up 1.5%

NASDAQ LRCX opened at $100.33 on Wednesday. The business has a fifty day moving average price of $97.90 and a 200 day moving average price of $84.22. Lam Research Corporation has a one year low of $56.32 and a one year high of $108.02. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The company has a market cap of $126.98 billion, a P/E ratio of 24.12, a P/E/G ratio of 1.28 and a beta of 1.65.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, beating the consensus estimate of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion during the quarter, compared to the consensus estimate of $4.99 billion. During the same period in the prior year, the company earned $1.03 EPS. The firm’s revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Analyst Ratings Changes

LRCX has been the subject of several research analyst reports. Needham & Company LLC upped their target price on Lam Research from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, July 31st. Citigroup upped their target price on Lam Research from $108.00 to $113.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Barclays set a $83.00 target price on Lam Research and gave the stock an “equal weight” rating in a research note on Monday, July 28th. KeyCorp increased their price objective on Lam Research from $105.00 to $115.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Finally, Wall Street Zen raised Lam Research from a “hold” rating to a “buy” rating in a research note on Saturday, August 2nd. Twenty equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $107.09.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.